Remifentanil-Sparing Effect of Pectoral Nerve Block Type II in Breast Surgery under Surgical Pleth Index-Guided Analgesia during Total Intravenous Anesthesia

• Published in: Journal of clinical medicine Vol. 8; no. 8; p. 1181
• Main Authors: Choi, Jung Ju, Jo, Youn Yi, Kim, Seung Hwan, Jung, Wol Seon, Lee, Dongchul, Kim, Kwan Yeong, Kwak, Hyun Jeong
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 07.08.2019
• Subjects: opioid consumption; Pecs II block; post-operative pain; breast cancer surgery
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm8081181

The pectoral nerve block type II (Pecs II block) can provide adequate perioperative analgesia in breast surgery. The surgical pleth index (SPI) is used to monitor the nociception balance using pulse oximetry. We investigated the remifentanil-sparing effect of Pecs II block under SPI guided analgesia during total intravenous anesthesia (TIVA). Thirty-nine patients undergoing breast surgery under remifentanil-propofol anesthesia were randomly assigned to the intervention (Pecs group, = 20) or control group ( = 19). Remifentanil and propofol concentrations were adjusted to maintain an SPI of 20-50 and a bispectral index of 40-60, respectively. The Pecs group received an ultrasound-guided Pecs II block preoperatively using 30 mL of 0.5% ropivacaine. Total infused remifentanil during the surgery was significantly less in the Pecs group than in the control group (6.8 ± 2.2 μg/kg/h vs. 10.1 ± 3.7 μg/kg/h, = 0.001). Pain scores on arrival at the postanesthetic care unit (PACU) (3 (2-5) vs. 5 (4-7)) and the rescue analgesic requirement in the PACU (9 vs. 2) was significantly lower in the Pecs group than in the control group. In conclusion, Pecs II block was able to reduce the intraoperative remifentanil consumption by approximately 30% and improve the postoperative pain in PACU in patients undergoing breast surgery under SPI-guided analgesia during TIVA.